Sharescart Research Club logo
Products
Research
Tools
About
  • Home
  • /
  • Shree Ganesh Remed
ChatGPT Claude Perplexity
Summarize with
ChatGPT Claude Perplexity
Join Channel

Shree Ganesh Remed.

WEBSITE BSE:540737 NSE: SGRL Inc. Year: 1995 Industry: Pharmaceuticals & Drugs My Bucket: Add Stock

₹514 -7.8 | 1.5%

Last updated: 11:32

Consolidated Standalone

Last updated: 11:32

Shree Ganesh Remed. Overview

Shree Ganesh Remedies Ltd is an primarily India-based organization. The Company is engaged in manufacturing and dispatching of drug intermediates and chemicals for pharmaceutical enterprise. The Company manufactures merchandise relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral. The Company’s merchandise portfolio encompass Di methyl amino propyl chloride HCl, Trityl chloride(TTCL), 4-Chloro 4 Fluoro Butyrophenone (CFBP), Sodium Bis (Trimethylsilyl) Amide in THF 1M/2M, Methyl Cyclo P...Read More

Want to Start Investing in Top Unlisted Stocks?

Our experts help you choose the right stocks based on performance, risk, and growth potential.

Shree Ganesh Remed. Key Financials

Market Cap ₹660 Cr.

Stock P/E 28.6

P/B 4.2

Current Price ₹514

Book Value ₹ 122

Face Value 10

52W High ₹794

Dividend Yield 0%

52W Low ₹ 381.1

Edit Ratio

Shree Ganesh Remed. Share Price

₹ | |

Volume
Price

Shree Ganesh Remed. Quarterly Price

Quarterly Monthly
Show Value Show %

Shree Ganesh Remed. Peer Comparison

Shree Ganesh Remed. Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Net Sales 17 21 37 25 32 27 24 25 30 21
Other Income 0 1 1 1 0 1 2 1 1 1
Total Income 17 22 39 25 33 28 27 25 31 22
Total Expenditure 13 15 20 17 21 17 15 17 21 14
Operating Profit 5 7 18 9 11 11 12 8 10 7
Interest 0 0 0 0 0 0 1 1 1 1
Depreciation 1 1 2 2 2 3 2 2 3 3
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 4 6 16 6 9 8 9 5 7 4
Provision for Tax 1 1 4 2 2 2 2 1 2 1
Profit After Tax 3 4 13 5 6 5 7 3 5 3
Adjustments 0 0 0 0 0 0 0 -0 -0 -0
Profit After Adjustments 3 4 13 5 6 5 7 3 5 3
Adjusted Earnings Per Share 2.5 3.5 10 3.6 5 4.2 5.1 2.7 3.9 2.4

Shree Ganesh Remed. Profit & Loss

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2024 Mar 2025 TTM
Net Sales 35 64 126 109 100
Other Income 1 4 3 4 5
Total Income 36 68 129 112 105
Total Expenditure 27 52 84 69 67
Operating Profit 10 16 45 43 37
Interest 0 1 1 2 4
Depreciation 1 2 6 10 10
Exceptional Income / Expenses 0 0 0 0 0
Profit Before Tax 9 14 38 31 25
Provision for Tax 2 3 10 8 6
Profit After Tax 6 10 28 23 18
Adjustments 0 0 0 0 0
Profit After Adjustments 6 10 28 23 18
Adjusted Earnings Per Share 5.2 8.7 21.9 18 14.1

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR -13% 46% 0% 0%
Operating Profit CAGR -4% 63% 0% 0%
PAT CAGR -18% 57% 0% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR -33% 19% 16% NA%
ROE Average 17% 26% 24% 24%
ROCE Average 20% 31% 29% 29%

Shree Ganesh Remed. Balance Sheet

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2024 Mar 2025
Shareholder's Funds 34 42 122 145
Minority's Interest 0 0 0 0
Borrowings 0 2 29 29
Other Non-Current Liabilities 0 0 1 1
Total Current Liabilities 7 10 26 24
Total Liabilities 41 55 178 200
Fixed Assets 14 20 81 95
Other Non-Current Assets 1 1 20 19
Total Current Assets 26 34 77 86
Total Assets 41 55 178 200

Shree Ganesh Remed. Cash Flow

#(Fig in Cr.) Mar 2019 Mar 2020 Mar 2024 Mar 2025
Opening Cash & Cash Equivalents 6 1 9 16
Cash Flow from Operating Activities -5 5 30 31
Cash Flow from Investing Activities -0 -3 -33 -36
Cash Flow from Financing Activities -0 -0 10 -1
Net Cash Inflow / Outflow -5 1 7 -6
Closing Cash & Cash Equivalent 1 2 16 10

Shree Ganesh Remed. Ratios

# Mar 2019 Mar 2020 Mar 2024 Mar 2025
Earnings Per Share (Rs) 5.16 8.66 21.89 17.97
CEPS(Rs) 6.01 10.56 26.64 25.42
DPS(Rs) 1.25 1.5 0 0
Book NAV/Share(Rs) 27.97 34.9 95.07 113.07
Core EBITDA Margin(%) 24.76 19.55 32.32 35.21
EBIT Margin(%) 25.12 22.08 29.97 29.97
Pre Tax Margin(%) 24.54 21.23 29.5 28.07
PAT Margin (%) 17.66 16.36 21.73 20.71
Cash Profit Margin (%) 20.6 19.94 26.46 29.3
ROA(%) 15.08 21.67 24.08 12.2
ROE(%) 18.43 27.55 34.22 17.26
ROCE(%) 25.66 34.79 37.81 19.53
Receivable days 100.48 78.42 53.79 69.81
Inventory Days 67.29 36.84 44.31 77.02
Payable days 76.9 40.52 40.38 72.01
PER(x) 7.79 6.21 30.49 39.58
Price/Book(x) 1.44 1.54 7.02 6.29
Dividend Yield(%) 2.31 2.07 0 0
EV/Net Sales(x) 1.37 1.05 6.97 8.67
EV/Core EBITDA(x) 4.88 4.09 19.54 21.92
Net Sales Growth(%) 0 81.28 96.65 -13.74
EBIT Growth(%) 0 59.32 174.32 -13.91
PAT Growth(%) 0 67.93 168.45 -17.93
EPS Growth(%) 0 67.93 152.78 -17.89
Debt/Equity(x) 0.02 0.11 0.3 0.26
Current Ratio(x) 3.8 3.26 2.98 3.53
Quick Ratio(x) 2.84 2.64 2.02 2.63
Interest Cover(x) 43.45 26.05 63.85 15.84
Total Debt/Mcap(x) 0.02 0.07 0.04 0.04

Shree Ganesh Remed. Shareholding Pattern

# Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Promoter 69.33 69.33 69.33 70.5 72.8 72.8 72.8 72.8 72.8 72.84
FII 0 0 0.01 0.01 0.01 0.01 0.01 0.01 0 0
DII 0 0 0 0 0 0 0 0 0 0
Public 30.67 30.67 30.66 29.5 27.19 27.19 27.19 27.19 27.2 27.16
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Shree Ganesh Remed. News

Shree Ganesh Remed. Pros & Cons

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 26%
  • Company is almost debt free.

Cons

  • Debtor days have increased from 40.38 to 72.01days.
  • Stock is trading at 4.2 times its book value.

* The pros and cons are machine generated.

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares
whatsapp

Please Login!

Click to Login
OR
Get free Account

Error!